Characteristic | Median (range) |
---|---|
Age (years) | 66 (48–78) |
TNM stage | |
T1c | 70.5% |
T2a | 24.2% |
T2b | 5.4% |
Gleason score | |
≤ 6 | 88.6% |
7 | 11.4% |
PSA (ng/ml) | 5.56 (0.88 - 18.46) |
< 10 | 89.8% |
≥10 | 10.2% |
IPSS (baseline) | 3 (0–24) |
≤ 3 | 57.6% |
>3 and ≤12 | 38.2% |
>12 | 4.2% |
Prostate baseline volume (cc) | 36.8 (14.4-67.7) |
No. of needles | 23 (16–32) |
No. of seeds | 58 (38–94) |
Activity (mCi) | 0.59 (0.4-0.65) |
High (≥0.5mCi) | 54.4% |
Low (<0.5mCi) | 45.6% |
No of seeds/needle | 2.6 (1.9-3.8) |